UCB Biosciences Inc. recalls cimzia (certolizumab pegol)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- cimzia (certolizumab pegol)
- Company
- UCB Biosciences Inc.
- Where it was sold
-
US Nationwide.
Nationwide
- Units affected
- 141,708 cartons
- About this recall
- cimzia (certolizumab pegol), 2x200mg/mL PREFILLED SYRINGES (2 single-dose), Rx ONLY, Manufactured by: UCB Inc., Smyrna, GA 30080, a) NDC 50474-710-79, b) Professional sample, NDC 50474-710-80; c) 3 cartons, STARTER KIT, NDC 50474-710-81.